Narjust Duma on How Gender Affects the Tolerability of Immunotherapy

Oncology (Williston Park). 2018 Jul 15;32(7):332-3.
No abstract available

Publication types

  • Interview

MeSH terms

  • Drug Tolerance
  • Humans
  • Immunotherapy*
  • Melanoma / drug therapy
  • Programmed Cell Death 1 Receptor / immunology*
  • Sex Factors
  • Skin Neoplasms / drug therapy

Substances

  • Programmed Cell Death 1 Receptor